by Embolization devices include balloons, coils, liquid embolics, and embolic agents that are delivered via a microcatheter. They help reduce or eliminate blood flow to abnormal vessels while preserving normal blood flow. Embolization techniques are used to treat conditions such as uterine fibroids, hemorrhage, cancers such as liver cancer and kidney cancer, arteriovenous malformations, and aneurysms.
The global Vascular Embolization Market is estimated to be valued at US$ 2084.49 Mn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The adoption of advanced embolization techniques such as radioembolization and drug-eluting bead embolization have accelerated market growth over the forecast period. Radioembolization uses microspheres that emit radiation internally to cut off blood supply to tumors. It offers better survival rates and fewer side effects than other therapies for liver cancer. Drug-eluting beads carry chemotherapy drug doxorubicin and release it directly into tumors over a period of time. This enhances treatment effectiveness while reducing systemic side effects. Their precise delivery of radiation or drugs has improved clinical outcomes in various cancers, boosting the vascular embolization market.
Segment Analysis
The global vascular embolization market can be segmented based on product type, procedure and end-use. The product type segment can be further divided into embolic agents, embolization devices, and accessories. The embolic agents sub-segment dominates the market owing to its high usage for blocking blood vessels during various vascular procedures. The procedure segment includes uterine artery embolization, tumor embolization, trauma embolization and others. The tumor embolization sub-segment holds the highest market share due to increasing prevalence of cancer across the globe. The end-use segment includes hospitals and clinics, ambulatory surgery centers and others. The hospitals and clinics sub-segment dominates as it is the primary location where various vascular procedures are performed.
Key Takeaways
The Global Vascular Embolization Market Size is expected to witness high growth over the forecast period. The global Vascular Embolization Market is estimated to be valued at US$ 2084.49 Mn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031.
Regional analysis:
North America leads the global vascular embolization market and is expected to maintain its dominance during the forecast period. This is attributed to factors such as presence of advanced healthcare infrastructure, rising healthcare spending, and increasing prevalence of target diseases in the region. Asia Pacific exhibits the fastest growth rate owing to growing patient base, rising medical tourism, and increasing awareness regarding embolization procedures in emerging economies of the region.
Key players:
Key players operating in the vascular embolization market are Boston Scientific Corporation (US), Medtronic plc (Ireland), Cook Medical (US), St. Jude Medical, Inc. (US), Terumo Corporation (Japan), and Penumbra, Inc. (US).
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
